ADS:
Chronic inflammatory process of the prostate gland is characterized by periodic recurrence of attacks of acute infectious lesions of the glandular tissue of the prostate. Most often, the hron form of prostatitis is formed as a result of neglected or untreated acute infectious prostatitis, the main pathogens in this pathology are Trichomonas and other urogenital infections.
The most common etiological factors in the development of chronic glandular tissue inflammation include infectious diseases. Chronic inflammatory process is dangerous not only by regular recurrence, but also by the gradual development of disorders in the functioning of the external genital organs and disorders in the reproductive properties of men. If the patient simply ignores the periodic courses of treatment, he has a risk of susceptibility to the development of malignant oncological pathologies in the tissues of the prostate.
It is necessary to highlight the main predisposing factors that are involved in the development of recurrence of the disease:
All possible etiopathogenic factors in the development of a chronic form of the course of the inflammatory process can be conditionally divided into two main groups:
There is a theory that intense nervous overstrain as a result of a sudden emotional shock or stress disorder may act as a predisposing factor.
In the period between the recurrence of the disease, symptomatic signs do not develop, only slight discomfort in the pelvic area can be felt, as a result of hypertrophy of the glandular tissue.
During the relapse period, symptoms such as:
With multiple recurrences of attacks of the disease, patients decide that the disease will go away on its own and do not carry out the necessary course of treatment. With the progression of inflammatory processes in the tissues of the prostate, signs of an intense spread of infection may develop, this often ends in acute renal failure.
The following diseases can act as complications of chronic inflammatory processes in the glandular tissue of the prostate:
In chronic prostatitis, patients receive only symptomatic and etiotropic treatment, since it is almost impossible to stop the pathogenetic mechanisms of the development of the disease with a drug method.
In order to eliminate signs of inflammatory changes in tissues and relieve pronounced pain syndrome, patients are prescribed non-steroidal anti-inflammatory drugs.
Depending on what type of bacterial pathogen is involved in the development of the disease, patients are prescribed etiotropic therapy with antibacterial drugs.
Medicines, the mechanism of action of which is based on blocking adrenergic receptors, are prescribed as antispasmodic conservative therapy. These drugs are able to relax the muscular apparatus of the perineum, thereby reducing the severity of pain.
Today Prostatilen is considered to be the drug of choice for chronic prostatitis.
This drug has the following pharmacological properties:
To maintain a long interictal period, patients are advised to regularly attend preventive consultations with a qualified urological specialist.
In order to prevent specific complications, the patients are advised to regularly carry out the necessary course of symptomatic and etiotropic treatment. A lot of an important point in preventive measures against chronic inflammatory processes is to reveal an active and physically yielding lifestyle. Supporting the rational nutritional mode contributes to the general strengthening of the body and an increase in the immune properties of the body.
Since this disease is characterized by a chronic pathogenetic flow mechanism, the forecast for further recovery is not favorable.